Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04750525 · ClinicalTrials.gov registry record · NA

A Non-invasive Intervention (BreEStim) for Management of Phantom Limb Pain (PLP) After Limb Amputation (Experiment 1)

A NA study of Pain Management, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT04750525 is a NA study of Pain Management that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 15 participants, below the 154-participant average among 31 other Pain Management trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04750525, a NA study of Pain Management, has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the effectiveness of innovative intervention of breathing controlled electrical stimulation (BreEStim) and conventional electrical stimulation (EStim) in management of neuropathic phantom limb pain in patients after limb amputation.

Conditions Studied

Interventions

  • DEVICE BreEStim
  • DEVICE EStim

Study Locations (1)

Texas

  • The University of Texas Health Science Center - Houston

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2021-04-02
Est. Completion 2023-03-10
Phase NA

What the Registry Record Tells You About NCT04750525

The ClinicalTrials.gov registry entry for NCT04750525 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 154-participant average among 31 other Pain Management trials with a reported enrollment target (90% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain Management appearing as the primary indexed condition, and to 2 interventions - of which BreEStim is the first listed.

NCT04750525 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT04750525 about?

NCT04750525 is a clinical study titled "A Non-invasive Intervention (BreEStim) for Management of Phantom Limb Pain (PLP) After Limb Amputation (Experiment 1)". The purpose of this study is to compare the effectiveness of innovative intervention of breathing controlled electrical stimulation (BreEStim) and conventional electrical stimulation (EStim) in management of neuropathic phantom limb pain in patients after limb amputation.

What is the current status of trial NCT04750525?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2021-04-02. Estimated completion is 2023-03-10.

What conditions does trial NCT04750525 study?

This clinical trial studies the following conditions: Pain Management.

What interventions are being tested in trial NCT04750525?

The interventions under investigation include: BreEStim (DEVICE), EStim (DEVICE).

Who is sponsoring clinical trial NCT04750525?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04750525 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain Management

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.